DIAmond Sessions

DIAmond Sessions offer unparalleled opportunities to engage with key opinion leaders and experts on the most pressing issues in healthcare, life sciences, and regulatory science. Join us in Washington, DC, as we drive forward groundbreaking solutions and shape the future of global health through collaboration, innovation, and bold conversations.

At DIA 2025, DIAmond Sessions will provide a platform for in-depth discussions on some of the most pressing challenges and innovations shaping the future of healthcare. This year’s sessions will explore the importance of women-focused research and development, rare disease product development, and the role of global IDMP standards in strengthening global supply chains. Designed to spark meaningful dialogue and drive actionable insights, these conversations will bring together diverse perspectives to advance progress across the industry.

• Monday, June 16

   Putting Patients First: Leveraging Global Identification of Medicinal Products Standards to Strengthen the Drug Supply Chain and Improve Lives

  11:00AM -12:00PM 
  

  This session will explore the critical role of Identification of Medicinal Products (IDMP) standards in addressing global healthcare challenges, such as pharmacovigilance, drug shortages, and medicinal product traceability.

  Learning Objectives

  • Discuss how IDMP standards address drug shortages by enhancing supply chain transparency and traceability
  • Identify the challenges and opportunities in implementing IDMP globally, focusing on the need for regulatory collaboration and interoperability
  • Explain the significance of global identifiers, such as PhPID, in ensuring consistent product identification across regions.

• Tuesday, June 17

   Redesigning Research and Development Policies with Women in Mind: Turning Ambition to Impact

  11:00AM -12:00PM 
  

  Discover how to redesign R&D policies with women in mind. Join experts to explore why women’s inclusion in clinical trials matters, what changes are needed, and how stakeholders can drive impact. Together, let's shape a more inclusive future for research.

  Learning Objectives

  • Evaluate the historical underrepresentation of women in clinical trials, its healthcare impact, and the role of initiatives in addressing gender disparities
  • Identify key policy changes and strategies for including gender considerations into clinical trial design
  • Develop actionable approaches to foster cross-sector collaboration among industry, regulatory bodies, government, and research institutions to advance gender diversity in clinical research

• Wednesday, June 18

   Rare but Real: Navigating Rare Disease Product Development and Market Access Challenges

  8:30-9:30AM 
  

  Experts representing industry, non-profit, research, regulatory, and payor perspectives will explore key hurdles and solutions to rare disease treatment development, from recruitment and diagnosis to late-stage development and access after accelerated approval.

• Identify hurdles and solutions to clinical trial recruitment, incl. early diagnosis and newborn screening
• Explore approaches to patient stratification, disease understanding, and novel biomarkers, while de-risking late-stage development in competitive and high-failure landscapes
• Examine challenges of market access and pricing after accelerated approval, and gain insights into addressing payer-specific concerns to ensure equitable access